FGFR2/Nrf-2 axis in luminal breast cancer and the effects on cell growth and response to anti-ER drugs
2020/37/N/NZ3/01401
Keywords
Descriptors
- NZ3_001: Biologia komórki
- NZ3_007: Przekaźnictwo sygnału
- NZ5_003: Patogeneza chorób człowieka
Panel
NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution
Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego
Voivodeship: pomorskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 19 – announced on 2020-03-16
- Amount awarded
- 210 000 PLN
- Project start date
- 2021-02-05
- Project end date
- 2025-02-04
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs
- Authors:
- Monika Gorska-Arcisz, Marta Popeda, Marcin Braun, Dominika Piasecka, Joanna I. Nowak, Kamila Kitowska, Grzegorz Stasilojc, Marcin Okroj, Hanna M. Romanska, Rafal Sadej
- Academic press:
- Cellular & Molecular Biology Letters (year: 2024, volume: 29, pages: numer artykułu: 71), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1186/s11658-024-00586-6 – link to the publication